Indirect Sinus Augmentation With and Without the Addition of a Biomaterial: A Randomized Controlled Clinical Trial
Indirect Sinus Augmentation With and Without the Addition of a Biomaterial: A Randomized Controlled Clinical Trial
复制标题
DOI：
10.1097/id.0000000000000941
复制
发表时间：
2019-12-01
影响因子：
--
通讯作者：
Thunyakitpisal, Pasutha
中科院分区：
文献类型：
--
作者：
Hai Anh Trinh;Van Viet Dam;Thunyakitpisal, Pasutha
目的：本研究的目的是比较有和没有添加生物材料的间接鼻窦增强的结果。材料与方法：30例40 ~ 60岁的随机对照临床试验。闭合性窦提升手术后，将患者随机等分分为血凝块控制组和阿赛曼南（14）海绵移植组。然后同时进行种植体放置。术后3个月和6个月分别行锥形束计算机断层扫描。通过种植体周围的x线片窦内骨增加率评估骨形成。结果：与对照组相比，阿西曼南治疗组在术后3个月和6个月的窦内骨增重率分别约为2.4倍和2倍，差异有统计学意义（P < 0.05）。结论：添加生物材料（阿塞曼南）间接窦性增强和同时植入可显著促进术后3和6个月的骨形成。
Purpose: The aim of this study was to compare the results of indirect sinus augmentation with and without the addition of a biomaterial.Materials and Methods: Thirty patients aged 40 to 60 years participated in this randomized controlled clinical trial. After closed sinus lift operation, patients were randomly and equally divided into blood clot control and acemannan(14) sponge graft groups. Simultaneous implant placement was then performed. Cone beam computed tomography was performed immediately and at 3 and 6 months postoperation. Bone formation was evaluated by the radiographic endo-sinus bone gain percentage around the implant.Results: Compared with the control group, the acemannan-treated group had a significantly greater radiographic endo-sinus bone gain percentage of approximately 2.4- and 2-fold at 3 and 6 months postsurgery, respectively (P < 0.05).Conclusion: The addition of a biomaterial (Acemannan) with indirect sinus augmentation and simultaneous implant placement significantly enhances bone formation at 3 and 6 months postsurgery.